Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Boston Bio, SeraCare deal

SRLS completed its previously announced purchase of BBII's BBI Diagnostics and BBI Biotech Research

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE